Summary Monoclonal antibodies (McAbs) directed against the framework determinants of Class I and Class II products of the major histocompatibility complex (MHC) and against leucocyte differentiation antigens were used in an indirect immunoperoxidase technique to study their expression in normal, benign (adenomatous polyps) and malignant disease of the colon. Class I products (detected by the McAb 2AI) were strongly expressed on all cell types in normal and benign tissues but some carcinomas exhibited a heterogenous pattern of epithelial cell staining and 4/15 were completely negative. Class II products (detected by TDR3 1.1) were strongly expressed on cells (mainly B lymphocytes) within the lamina propria. In carcinomas TDR31.1 staining was mainly interstitial, but in 2/15, DR+ epithelial cells were also detected. In normal and benign tissues, leucocytes (reactive with 2D1) found predominantly in the lamina propria, comprised T cells mainly of the helper/inducer (OKT4) subset, DR+ cells in approx. equivalent proportion and a few OKM1+ cells mostly of macrophage morphology. Occasional intraepithelial lymphocytes were of cytotoxic/suppressor (OKT8) phenotype. In malignant neoplasms, there was wide inter and intra-tumour variation in the proportion of leucocytes which were heterogeneous with respect to cell type and confined mainly to the stroma. T cells were consistently predominant, but B cells and macrophages were also present. Two neoplasms showed unequivocal evidence of a shift (relative to peripheral blood) in favour of the OKT8+ subset, but in the majority of tumours OKT4+; and OKT8+ cells were present in roughly similar proportions. Natural killer cells (monitored with Leu7, HNK1) were virtually undetectable in both normal and malignant tissues. There were no apparent correlations between the extent and type of leucocyte infiltration, tumour differentiation or expression of MHC products. Some implications for the extrapolation of in vitro data on leucocyte function to the in vivo situation are discussed.
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There is increasing awareness that the biological behaviour of tumour cells, which varies widely between neoplasms of the same histological type and grade, is dictated to a large extent by interaction with neighbouring cells and their environment in general.
The correlation between the presence of intra tumour inflammatory cells and prognosis which appears to exist for some neoplasms, suggests that infiltrative leucocytes may constitute a potentially important component of the interface between tumours and the normal cells of the host. (Underwood, 1974; loachim, 1976 ; see also Haskill, 1982; Moore, 1984) . Whether the defensive role frequently attributed to inflammatory cells is a consequence of direct effector functions (as suggested by in vitro studies), or a secondary phenomenon unrelated to the capacity of the tumour to evoke an immune response, is not altogether clear.
Extensive in vitro studies suggest that for some tumours there is a correlation between systemic anti-tumour immunity and prognosis (Vanky et al., 1983a,b) . Limited functional data are also available for leucocytes recovered from the tumour site, but the coexistence of populations with cytotoxic activity (Totterman et al., 1978 , Werkmeister et al., 1979 Vose et al., 1981) as well as suppressive activity (Vose & Moore, 1979) , has rendered the interpretation of in situ events difficult.
With the advent of monoclonal antibodies to leucocyte populations and their subsets it is possible to examine the heterogeneity of the inflammatory response to neoplasia under conditions where the microanatomical relationships between potential effector cells and the neoplastic population, crucial to the extrapolation of in vitro data to in vivo events, are maintained (Rowe & Beverley, 1984; Whitwell et al., 1984; Bhan & Des Marais, 1983; Watanabe et al., 1983 , Ruiter et al., 1982 . The approach also has the advantage that properties of the plasma membranes of tumour cells (e.g. expression of MHC products) critical for certain types of immune interaction, may be simultaneously examined (Fleming et al., 1981; Daar et al., 1982; Daar & Fabre, 1983 ).
We present herein a preliminary study of human colon carcinoma, against which systemic and in situ immune reactivity have been demonstrated and for which a positive correlation exists between lymphoid infiltration and prognosis (Murray et al., 1975; Spratt & Spjut, 1967; Watt & House, 1978; Svennevig et al., 1984) . For this purpose we have compared the expression of histocompatibility and leucocyte differentiation antigens in normal colon and in benign (adenomatous polyps) and malignant tumours.
Patients and methods
The patients were all admitted for resection of large bowel tumours diagnosed prior to operation radiologically or by biopsy. Histological confirmation and staging were done on paraffin sections. Normal large bowel away from the tumour was examined in eight of the fifteen cases. Three of the cases had associated small tubulovillous adenomata which were also included.
The age range of patients (9 males; 6 females) was 59-83 years. The sites of the primary tumour are listed in Table II (Whitwell et al., 1984) and are summarized in Table I Normal colon MHC Class I products (reactive with 2A1) were strongly expressed on all cell types in normal colon, with the exception of the submucosa where staining was most clearly associated with lining cells of the submucosal blood vessels (Figure 1) .
MHC Class II products (reactive with TDR3 1.1) were strongly expressed in the lamina propria; the most intense staining consisting of densely packed leucocytes polarized towards the lumen. All epithelial cells were negative.
Leucocytes (reactive with 2D1) were found mainly in the mucosa, with a few cells scattered within the submucosa, and predominantly in the lamina propria. Occasional intraepithelial leucocytes were detectable. T lymphocytes (reactive with UCHT1) were found mainly in the lamina propria where they were randomly distributed in some areas and present as aggregates in others. T cells accounted for approx. one third of lamina propria leucocytes, but intraepithelial T cells were identified only occasionally. The helper-inducer subset (OKT4+) exceeded the cytotoxic/suppressor subset (OKT8+) in the lamina propria, the ratio being of the order of 3:2. The few T cells identified in the luminal and glandular epithelium appeared to be predominantly of OKT8 phenotype.
B cells (detected with MAS 020) were detected predominantly in juxtaposition to the luminal epithelium. In this respect, the staining pattern resembled, but was not identical with that of the anti-MHC Class II McAb (TDR31.1). The (Figure 2) , while in the remaining moderate-topoorly differentiated tumours the pattern of staining was either heterogenous (Figure 3) (Ortaldo et al., 1981) . Leu 7+ (HNK I+) cells were in fact negligible in the seven tumours examined with this reagent.
Discussion
These data confirm that in common with most normal epithelia, there is strong expression of MHC Class I products, but not of Class II products, on normal colorectal epithelium (Daar & Fabre, 1983) . Similarly, in common with other normal tissues, the distribution of various leucocytes and their subsets within the colorectal mucosa is spatially ordered and predictable (Selby et al., 1981) . Leucocytes are principally represented in the lamina propria, where the major T cell subset is of helper/inducer phenotype. Its primary role in association with macrophages and other antigenpresenting cells may be to provide local B cell help.
The association of cytotoxic/suppressor lymphocytes with HLA Class I-positive, Class IInegative epithelium on the other hand, suggests that their role in the local immune response is interaction with epithelial cells altered by viral infection or other foreign (non-self) antigens (Selby et al., 1981) . HNK1+ cells, attributed with NK/K cell activity were not significantly represented in either the epithelium or lamina propria.
With the possible exception of DR' cells in the glandular epithelium of one adenoma, the pattern and intensity of staining of these lesions with the panel of McAbs scarcely differed from that of normal colon. By contrast, the expression of MHC products and the extent and type of leucocyte infiltration in malignant tumours was far less predictable. The most conspicuous differences were in respect of loss of Class I antigen expression and gain of Class II products. Four of 15 adenocarcinomas failed to express Class I antigens at all, in 2/15 expression was heterogenous, while 2/15 expressed Class II products. The data indicate that loss of MHC Class I products at least, is not unusual, being encountered in breast carcinoma (Fleming et al., 1981; Bhan & Des Marais, 1983; Rowe & Beverley, 1984) ; gynaecological neoplasms (Ferguson & Moore, unpublished data) and colorectal cancer (Daar & Fabre 1983) alike. In this pilot series, there was no apparent correlation between the expression of either class of MHC product and the degree of differentiation or the extent and type of leucocyte infiltration.
The loss of Class I antigen expression has implications for the associative recognition of putatively antigenic tumour cells by cytotoxic T lymphocytes (McMichael, 1978) . The Class Inegative populations could conceivably have arisen through immunoselection of Class I-positive clones expressing tumour-associated antigens. On this hypothesis, given the evidence for lymphocyte recognition of colorectal cancer cells, (Werkmeister et al., 1979; Vose et al., 1981) Marais, 1983; Pizzolo et al., 1984; Watanabe et al., 1983; Whitwell et al., 1984) . Even allowing for the fact that not all peripheral blood NK activity is represented in the Leu 7+ (HNK1 +) population, (Abo et al., 1982b) recent (unpublished) immunohistological experience with the B73.1 monoclonal antibody (Perussia et al., 1983 a, b) and extensive functional data Vose et al., 1981; Eremin et al., 1981; Introna et al., 1983) are consistent with a paucity of NK cells at the tumour site.
The relatively infrequent expression of DR antigen on carcinoma cells in this series may be a consequence of patient selection since poorly differentiated tumours which are associated with a more uniform expression of HLA-DR (Rognam et al., 1983) were a minority. The extent of any similarity with the expression of these determinants on human bronchial, intestinal and mammary epithelia (Natali et al., 1981) -where extrinsic factors such as hormonal changes associated with pregnancy and lactation (Klareskog et al., 1980) and the development of graft versus host disease (Lampert et al., 1981; Mason et al., 1981) are influential -is presently unknown. DR antigen could conceivably augment tumour-associated T cell immune responses (Thompson et al., 1982; Guerry et al., 1984) and there is currently much interest in the observation that cytotoxic cells of T4 phenotype are restricted by Class II determinants (Reinherz et al., 1983) .
Analysis of leucocyte infiltrates indicated that these were predominantly to be found in the interstitial connective tissue. Our observation that cells of T8 phenotype either exceeded or were present in approximately equal numbers to those of T4 phenotype is suggestive of some tissue selection in favour of the cytotoxic/suppressor subset. However, the factors which determine this ingress, including the extent to which tumour immunogenicity plays a role in the process, are unknown. On immunohistological evidence alone, predominance of the T8 subset might imply a preponderance of either cytotoxic or suppressor T cells at the tumour site. A positive relationship between leucocyte infiltration and survival in a subgroup of Dukes B patients has been asserted (Svennevig et al., 1984) and some in vitro functional data are also consistent with a defensive antitumour role for inflammatory cells (Werkmeister et al., 1979; Vose et al., 1981) . However, intra-tumour leucocytes also comprise suppressor T cells (Vose & Moore, 1979 
